The rediscovery of platinum-based cancer therapy.

Rottenberg, Sven; Disler, Carmen; Perego, Paola (2021). The rediscovery of platinum-based cancer therapy. Nature reviews - cancer, 21(1), pp. 37-50. Nature Publishing Group 10.1038/s41568-020-00308-y

[img] Text
b152658.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB)

Platinum (Pt) compounds entered the clinic as anticancer agents when cisplatin was approved in 1978. More than 40 years later, even in the era of precision medicine and immunotherapy, Pt drugs remain among the most widely used anticancer drugs. As Pt drugs mainly target DNA, it is not surprising that recent insights into alterations of DNA repair mechanisms provide a useful explanation for their success. Many cancers have defective DNA repair, a feature that also sheds new light on the mechanisms of secondary drug resistance, such as the restoration of DNA repair pathways. In addition, genome-wide functional screening approaches have revealed interesting insights into Pt drug uptake. About half of cisplatin and carboplatin but not oxaliplatin may enter cells through the widely expressed volume-regulated anion channel (VRAC). The analysis of this heteromeric channel in tumour biopsies may therefore be a useful biomarker to stratify patients for initial Pt treatments. Moreover, Pt-based approaches may be improved in the future by the optimization of combinations with immunotherapy, management of side effects and use of nanodelivery devices. Hence, Pt drugs may still be part of the standard of care for several cancers in the coming years.

Item Type:

Journal Article (Review Article)

Division/Institute:

05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute of Animal Pathology
05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP)
04 Faculty of Medicine > Faculty Institutions > Bern Center for Precision Medicine (BCPM)

UniBE Contributor:

Rottenberg, Sven, Widmer, Carmen

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health
600 Technology > 630 Agriculture

ISSN:

1474-175X

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Pamela Schumacher

Date Deposited:

23 Mar 2021 15:28

Last Modified:

02 Mar 2023 23:34

Publisher DOI:

10.1038/s41568-020-00308-y

PubMed ID:

33128031

BORIS DOI:

10.48350/152658

URI:

https://boris.unibe.ch/id/eprint/152658

Actions (login required)

Edit item Edit item
Provide Feedback